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b The total cytochrome P450 content in microsomes was determined from CO difference spectra of dithionite-reduced microsomes using an extinction coefficient of 91 cm -1 mM -1 between A 450 and A 490 . Table S2 . Liver-specific cpr deletion of the cytochrome P450 reductase gene has no significant effect on transcript levels of plasticity-associated genes a across different brain regions (i.e., cortex, hippocampus and cerebellum), as determined using quantitative polymerase chain reaction (qPCR). b The observation that the liver-specific deletion of the cpr gene does not, in and of itself, interfere with markers of neurodevelopment suggest that this transgenic mouse model is a potentially useful genetic model to study how hepatic metabolism modulates the developmental neurotoxicity of PCBs.
Gene

Cortex
Hippocampus Cerebellum a Four plasticity-associated genes were selected based on earlier studies demonstrating their usefulness as biomarkers of synaptic plasticity. ARC is an immediate early gene whose expression is modulated by activity, and it plays a critical role in AMPA receptor trafficking and synaptic plasticity in general. 4 SPN 5, 6 and RC3/neurogranin 7 are selectively localized to postsynaptic densities, and are implicated in regulating synaptic plasticity. Because they are induced by activity, spinophilin and ARC are useful biomarkers of not only synapse density but also synaptic plasticity. 8, 9 RC3/neurogranin is of particular interest in the context of POP neurotoxicity because it is encoded by a thyroid-responsive gene and its transcription is upregulated by POPs. 10, 11 b Transcript levels of activity-regulated cytoskeleton-associated protein (ARC), myelin basic protein (MBP), neurogranin (RC3), and spinophilin (SPN) were measured by qPCR as biomarkers of synaptic plasticity in hippocampi, cortices, and cerebella in untreated KO (n=10) and age-matched congenic WT mice (n=6). Briefly, tissue samples were collected in 600 µL of Buffer RLT (Qiagen, Germantown, MD) with β-mercaptoethanol (Bio-Rad, Hercules, CA) and stored at -20 °C. Two grinding beads (4-mm diameter, stainless steel beads, SpexCertiprep, Metuchen, NJ) were added and the tissues were homogenized in a GenoGrinder 2000 (SpexCertiprep) for 2 min at 1000 strokes per minute. Total RNA was extracted from the tissue lysates using a BioSprint automated nucleic acid workstation (Qiagen) according to manufacturer instructions for the One-For-All Vet Kit (Qiagen). The Quantitect Reverse Transcription Kit (Qiagen) was used for cDNA synthesis following manufacturer instructions with previously described modifications. 12 Each qPCR reaction contained a final concentration of 400 nM of each primer and 80 nM of the TaqMan probe diluted in Taqman Universal PCR Master Mix (TaqMan, Applied Biosystems, Foster City, CA, USA). Five µL of cDNA was added to 384-well plates in duplicate and amplified in an automated fluorometer (ABI PRISM ® 7900 HT fast detection system, Carlsbad, CA, USA). Amplification conditions have previously been described. 13 Fluorescent signals were collected during the annealing temperature and quantification cycle (Cq) values extracted with a threshold of 0.2 and baseline values of 3-15. Sequences of primers and probes used for qPCR assessment of synaptic plasticity-associated genes are presented in Table S2a ; amplification efficiencies of reference and synaptic plasticity-associated genes are summarized in Table S2b . c Changes in gene expression are expressed as fold-change in expression between target and reference genes in KO relative to WT mice. Hypoxanthine-guanine phosphoribosyltransferase (HPRT), phosphoglycerate kinase (PGK1), and peptidylprolyl isomerase A (PPIA) were measured as reference genes. 
